Our study found that patients using semaglutide 1 mg have a higher risk of depression, anxiety, and suicidal ideation when compared with non-semaglutide users, irrespective of age and sex differences
Non-diabetic patients who received 15mg weekly for 72 weeks (about 17 months) lost an average of 22.5% of their body weight, compared to 2.4% of the placebo group
No matter what I did running, walking, I would walk for hours because they say that's good, I literally was playing a professional sport and I could never go back to where I needed to be for my health
Wegovy and Zepbound are now fully FDA approved for chronic weight management, regardless of diabetes status, as long as you meet the BMI or health condition criteria
Anyone expecting results similar to Ozempic or Wegovy will likely be disappointed